Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: Abatacept;   Drug: Placebo Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified November 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials